CLOVER HEALTH INVESTMENTS, CORP. /DE — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CLOVER HEALTH INVESTMENTS, CORP. /DE filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.92B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.37B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.26B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.47B | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $672.89M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $462.27M | Feb 28, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $257.33M | Mar 14, 2024 |
| FY2023 | Dec 31, 2022 | $22.74M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($79.18M) | Mar 1, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($85.55M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($43.01M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($213.36M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($339.57M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($587.76M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($136.39M) | Mar 1, 2023 |
| FY2020 | Dec 31, 2019 | ($17.6K) | Mar 31, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($85.53M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($45.75M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($205.33M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($286.66M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($636.99M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($92.71M) | Mar 1, 2023 |
| FY2020 | Dec 31, 2019 | ($17.6K) | Mar 31, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($66.93M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $34.85M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($144.66M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($203.93M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($282.33M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($118.50M) | Mar 1, 2023 |
| FY2020 | Dec 31, 2019 | ($17.6K) | Mar 31, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.04M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.56M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $584.0K | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.47M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $723.0K | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $693.0K | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $23.0K | Feb 28, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $541.01M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $580.74M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $570.67M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $808.62M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $950.80M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $267.25M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $100.3K | Mar 31, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $232.31M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $239.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $284.28M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $451.73M | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | $410.76M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $432.70M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $118.0K | Mar 31, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $347.74M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $535.41M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($617.10M) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($17.6K) | Mar 31, 2021 |
| FY2020 | Oct 17, 2019 | $0 | Mar 31, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Mar 14, 2024 |
| FY2023 | Dec 31, 2022 | $11.75M | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | $1.24M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $1.24M | Mar 1, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.29B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($2.20B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($2.16B) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | ($1.95B) | Mar 14, 2024 |
| FY2023 | Jan 1, 2022 | $1.62B | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | ($1.62B) | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | ($1.03B) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($17.6K) | Mar 31, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $194.54M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $122.86M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $103.79M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $299.97M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $92.35M | Mar 1, 2023 |
| FY2020 | Dec 31, 2019 | $0 | Mar 31, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $20.00M | Feb 28, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Mar 14, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | (1) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | (4) | Feb 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Mar 14, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | (1) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | (4) | Feb 28, 2022 |